India's Crisis: Tackling the Viral Hepatitis Burden

The Hepatitis burden in India remains a significant public health threat. According to the WHO Global Hepatitis Report 2026, the world is struggling to meet the 2030 elimination targets. Specifically, India ranks as one of the hardest-hit nations globally. Furthermore, viral hepatitis caused over 1.3 million deaths in 2024. Most of these fatalities resulted from Hepatitis B and C infections. These \"silent\" viruses often lead to cirrhosis and liver cancer if left untreated.

Analyzing the Hepatitis Burden in India

India accounts for a massive portion of the global disease load. Consequently, the country contributes to nearly 69% of global Hepatitis B deaths. It also represents 58% of global Hepatitis C deaths. Currently, India has the second-largest Hepatitis C burden, trailing only Pakistan. Estimates suggest around 40 million people live with chronic Hepatitis B in the country. Therefore, prevalence stays high at approximately 2% to 4% among the population.

Gaps in Screening and Diagnosis

Medical experts emphasize that the primary challenge is under-diagnosis rather than treatment access. Many patients remain unaware of their status for decades. Moreover, gaps in vaccination coverage and unsafe medical practices persist. Routine screening for pregnant women is often missed, leading to mother-to-child transmission. While Hepatitis C treatment is free and effective, long-term compliance remains weak. Thus, eliminating the virus by 2030 appears increasingly unlikely at the current pace.

Addressing Treatment Access and Vaccination

Globally, only 5% of Hepatitis B patients receive necessary therapy. Similarly, only 20% of eligible Hepatitis C patients have accessed treatment. Hepatitis B infections often occur during early childhood. In contrast, Hepatitis C spreads primarily through unsafe blood exposure and needle sharing. To improve outcomes, clinicians must scale up screening and safer medical practices. Finally, public awareness campaigns are essential to boost routine testing rates across the nation.

Frequently Asked Questions

Q1: What are the primary causes of the high hepatitis burden in India?

The high burden stems from gaps in vaccination, under-diagnosis, and unsafe exposures such as needle sharing or razor reuse. Mother-to-child transmission also plays a significant role in Hepatitis B prevalence.

Q2: Why is the 2030 elimination target at risk?

Progress is too slow because of low screening rates and limited treatment access. Despite the availability of affordable drugs, many people remain undiagnosed until the disease reaches advanced stages like cirrhosis.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. India among worst-hit as hepatitis deaths stay high despite global gains: WHOreport - ETHealthworld


2. World Health Organization (WHO). Global Hepatitis Report 2024/2026.


3. Indian Council of Medical Research (ICMR). Hepatitis Prevalence and Screening Guidelines.